New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
1
10

Drugs from the Sea, and Thalidomide at 50 - The Naked Scientists

Naked Scientists - 27th Aug 2011 - Drugs from the Sea, and Thalidomide at 50  
thenakedscientists.com
about 5 years ago
Preview
1
26

Smart Pills: Drugs to Boost Brain Power - The Naked Scientists

Naked Scientists - 21st Nov 2010 - Smart Pills: Drugs to Boost Brain Power  
thenakedscientists.com
about 5 years ago
Preview
1
37

Minister 'open-minded' on legal high solutions - BBC News

Crime minister Norman Baker says "all options" are being considered on the problem of legal highs, after the Home Office ruled out licensing of shops.  
BBC News
about 5 years ago
Preview
1
8

EAHP 2014: European Summit on Hospital Pharmacy

Stream EAHP 2014: European Summit on Hospital Pharmacy by BMJ talk medicine from desktop or your mobile device  
SoundCloud
about 5 years ago
Preview
1
8

EAHP 2014: The hospital pharmacist in 2020

Stream EAHP 2014: The hospital pharmacist in 2020 by BMJ talk medicine from desktop or your mobile device  
SoundCloud
about 5 years ago
Preview
1
9

EAHP 2014: Innovation in pharmacy

Stream EAHP 2014: Innovation in pharmacy by BMJ talk medicine from desktop or your mobile device  
SoundCloud
about 5 years ago
Preview
1
8

Communication between hospital and community pharmacists

Stream Communication between hospital and community pharmacists by BMJ talk medicine from desktop or your mobile device  
SoundCloud
about 5 years ago
Preview
1
7

The hospital pharmacist’s impact on patient care

Stream The hospital pharmacist’s impact on patient care by BMJ talk medicine from desktop or your mobile device  
SoundCloud
about 5 years ago
Preview
1
20

ISCD ~ Independent Scientific Committee on Drugs

In clear and accessible language, Professor David Nutt’s Drugs Without the Hot Air argues the case for an evidence-based approach, challenging elements of drug policy and myths on the relative harms of legal and illegal drugs.  
drugscience.org.uk
about 5 years ago
Preview
1
27

Painful diabetic neuropathy

Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat this condition. Diagnostic tests in this field are evolving rapidly. These include the use of skin biopsies to measure small unmyelinated fibers, as well as even newer techniques that can measure both small unmyelinated fibers and large myelinated fibers in the same biopsy. The main treatments for painful diabetic neuropathy remain management of the underlying diabetes and drugs for the relief of pain. However, emerging evidence points to major differences between type 1 and type 2 diabetes, including the ability of glycemic control to prevent neuropathy. Enhanced glucose control is much more effective at preventing neuropathy in patients with type 1 diabetes than in those with type 2 disease. This dichotomy emphasizes the need to study the pathophysiologic differences between the two types of diabetes, because different treatments may be needed for each condition. The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. Finally, neuropathic pain is under-recognized and undertreated despite an ever evolving list of effective drugs. Evidence exists to support several drugs, but the optimal sequence and combination of these drugs are still to be determined.  
www.bmj.com
about 5 years ago
Preview
1
18

Painful diabetic neuropathy

Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat this condition. Diagnostic tests in this field are evolving rapidly. These include the use of skin biopsies to measure small unmyelinated fibers, as well as even newer techniques that can measure both small unmyelinated fibers and large myelinated fibers in the same biopsy. The main treatments for painful diabetic neuropathy remain management of the underlying diabetes and drugs for the relief of pain. However, emerging evidence points to major differences between type 1 and type 2 diabetes, including the ability of glycemic control to prevent neuropathy. Enhanced glucose control is much more effective at preventing neuropathy in patients with type 1 diabetes than in those with type 2 disease. This dichotomy emphasizes the need to study the pathophysiologic differences between the two types of diabetes, because different treatments may be needed for each condition. The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. Finally, neuropathic pain is under-recognized and undertreated despite an ever evolving list of effective drugs. Evidence exists to support several drugs, but the optimal sequence and combination of these drugs are still to be determined.  
www.bmj.com
about 5 years ago
Preview
1
15

Painful diabetic neuropathy

Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat this condition. Diagnostic tests in this field are evolving rapidly. These include the use of skin biopsies to measure small unmyelinated fibers, as well as even newer techniques that can measure both small unmyelinated fibers and large myelinated fibers in the same biopsy. The main treatments for painful diabetic neuropathy remain management of the underlying diabetes and drugs for the relief of pain. However, emerging evidence points to major differences between type 1 and type 2 diabetes, including the ability of glycemic control to prevent neuropathy. Enhanced glucose control is much more effective at preventing neuropathy in patients with type 1 diabetes than in those with type 2 disease. This dichotomy emphasizes the need to study the pathophysiologic differences between the two types of diabetes, because different treatments may be needed for each condition. The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. Finally, neuropathic pain is under-recognized and undertreated despite an ever evolving list of effective drugs. Evidence exists to support several drugs, but the optimal sequence and combination of these drugs are still to be determined.  
www.bmj.com
about 5 years ago
Preview
1
52

Painful diabetic neuropathy

Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat this condition. Diagnostic tests in this field are evolving rapidly. These include the use of skin biopsies to measure small unmyelinated fibers, as well as even newer techniques that can measure both small unmyelinated fibers and large myelinated fibers in the same biopsy. The main treatments for painful diabetic neuropathy remain management of the underlying diabetes and drugs for the relief of pain. However, emerging evidence points to major differences between type 1 and type 2 diabetes, including the ability of glycemic control to prevent neuropathy. Enhanced glucose control is much more effective at preventing neuropathy in patients with type 1 diabetes than in those with type 2 disease. This dichotomy emphasizes the need to study the pathophysiologic differences between the two types of diabetes, because different treatments may be needed for each condition. The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. Finally, neuropathic pain is under-recognized and undertreated despite an ever evolving list of effective drugs. Evidence exists to support several drugs, but the optimal sequence and combination of these drugs are still to be determined.  
www.bmj.com
about 5 years ago
Preview
1
13

Painful diabetic neuropathy

Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat this condition. Diagnostic tests in this field are evolving rapidly. These include the use of skin biopsies to measure small unmyelinated fibers, as well as even newer techniques that can measure both small unmyelinated fibers and large myelinated fibers in the same biopsy. The main treatments for painful diabetic neuropathy remain management of the underlying diabetes and drugs for the relief of pain. However, emerging evidence points to major differences between type 1 and type 2 diabetes, including the ability of glycemic control to prevent neuropathy. Enhanced glucose control is much more effective at preventing neuropathy in patients with type 1 diabetes than in those with type 2 disease. This dichotomy emphasizes the need to study the pathophysiologic differences between the two types of diabetes, because different treatments may be needed for each condition. The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. Finally, neuropathic pain is under-recognized and undertreated despite an ever evolving list of effective drugs. Evidence exists to support several drugs, but the optimal sequence and combination of these drugs are still to be determined.  
www.bmj.com
about 5 years ago
Preview
1
15

Mobile Surgical

Mobile Health Solutions (MHS) has proven that sharing expensive medical resources enables better care to be delivered closer to the homes of rural New Zealanders.  
mobilesurgical.co.nz
about 5 years ago
Preview
2
97

Pharmacology Local Anaesthetic

More Anatomy Lessons : https://www.youtube.com/user/AnatomyProfStudent Anatomy video Anatomy vagin Anatomy penis Anatomy prof students Anatomy videos medical...  
YouTube
about 5 years ago
Preview
3
165

Pharmacology Glucocorticoids

More Anatomy Lessons : https://www.youtube.com/user/AnatomyProfStudent Anatomy video Anatomy vagin Anatomy penis Anatomy prof students Anatomy videos medical...  
YouTube
about 5 years ago
Preview
3
193

Pharmacokinetics 2 - Absorption

http://www.handwrittentutorials.com - This tutorial is the second in the Pharmacokinetics series. This tutorial discusses Routes of Administration and how th...  
YouTube
about 5 years ago
Preview
1
83

110 Hypertension Treatment

http://www.interactive-biology.com - What are the mechanisms that underly the drugs that are used to treat hypertension? Drugs like ACE inhibitors, diuretics...  
YouTube
about 5 years ago
Preview
2
39

Pharmacology - Cholinergic Blockers Part 1

The online lecture series for medical students. On demand streaming video lectures. www.mdcrack.tv Owner: MD CRACK  
YouTube
about 5 years ago